Herbal medicinal products or preparations for neuropathic pain.
Sign Up to like & getrecommendations! Published in 2017 at "Cochrane Database of Systematic Reviews"
DOI: 10.1002/14651858.cd010528.pub3
Abstract: BACKGROUND Neuropathic pain is a consequence of damage to the central nervous system (CNS), for example, cerebrovascular accident, multiple sclerosis or spinal cord injury, or peripheral nervous system (PNS), for example, painful diabetic neuropathy (PDN),… read more here.
Keywords: medicinal products; evidence; effect; herbal medicinal ... See more keywords
European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006-2020.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical pharmacology and therapeutics"
DOI: 10.1002/cpt.2906
Abstract: Since 2006, the European conditional marketing authorization (CMA) aims to facilitate timely patient access to medicinal products for which there is an unmet medical need by accepting less comprehensive data than normally required. The granting… read more here.
Keywords: european conditional; conditional marketing; marketing authorization; anticancer medicinal ... See more keywords
NICE on the use of cannabis‐based medicinal products
Sign Up to like & getrecommendations! Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1838
Abstract: This article provides a summary of the recent NICE recommendations on the use of cannabis‐based medicinal products (CBMPs) in the treatment of epilepsy, spasticity, pain, and nausea and vomiting. It also discusses the guidance on… read more here.
Keywords: based medicinal; medicinal products; cannabis based; use cannabis ... See more keywords
New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and Pricing
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-021-01041-6
Abstract: New specialized therapeutics coming to market, such as advanced therapy medicinal products (ATMPs) and orphan drugs, differ from traditional therapies in terms of how they are manufactured and administered, as well as the potentially transformative… read more here.
Keywords: technology assessment; medicinal products; health technology;
Medical Devices: Definition, Classification, and Regulatory Implications
Sign Up to like & getrecommendations! Published in 2019 at "Drug Safety"
DOI: 10.1007/s40264-019-00878-3
Abstract: We propose the following definition of a medical device: “A contrivance designed and manufactured for use in healthcare, and not solely medicinal or nutritional.” Current regulatory classifications of medical devices are complex and designed primarily… read more here.
Keywords: definition; classification; devices definition; medicinal products ... See more keywords
Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered
Sign Up to like & getrecommendations! Published in 2018 at "Pharmaceutical Medicine"
DOI: 10.1007/s40290-018-0243-9
Abstract: To attain effective and safe pharmacotherapy, formulations in (pre)term neonates should enable extensive dose flexibility. During product development and subsequent authorization and clinical use of such formulations, there is also a need for informed decisions… read more here.
Keywords: excipients neonatal; neonatal medicinal; knowledge; medicinal products ... See more keywords
PSY147 - AVAILABILITY AND REIMBURSEMENT OF ORPHAN DRUGS IN THE CZECH REPUBLIC
Sign Up to like & getrecommendations! Published in 2018 at "Value in Health"
DOI: 10.1016/j.jval.2018.09.2721
Abstract: 1 Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products, O.J. L 18, 22.1.2000. • 2 Ornstova E, Sebestianova M, Mlcoch T, Lamblova K,… read more here.
Keywords: medicinal products; available http; czech republic; orphan medicinal ... See more keywords
Herbal medicinal products in pregnancy - which data are available?
Sign Up to like & getrecommendations! Published in 2017 at "Reproductive toxicology"
DOI: 10.1016/j.reprotox.2017.06.046
Abstract: This review aims to highlight recent approaches concerning usage of (traditional) herbal medicinal products in pregnancy and to discuss appropriate strategies to handle limited information. Therefore, published monographs of the Committee on Herbal Medicinal products… read more here.
Keywords: medicinal products; pregnancy data; herbal medicinal; products pregnancy ... See more keywords
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
Sign Up to like & getrecommendations! Published in 2022 at "Neuropediatrics"
DOI: 10.1055/a-2002-2119
Abstract: Abstract Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment of treatment-resistant epilepsy (TRE) in children. Methods A case series of children ( read more here.
Keywords: cannabis; cannabis based; medicinal products; based medicinal ... See more keywords
Price of medicines in a small market country: a comparative approach
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Pharmaceutical Health Services Research"
DOI: 10.1093/jphsr/rmab004
Abstract: Affordability and availability of medicinal products depend on governmental policies, healthcare budgets and pricing. Pharmaceutical price regulation can improve the accessibility and affordability of essential medicinal products. In Europe, medicinal product prices are assigned individually… read more here.
Keywords: medicines small; country; price medicines; medicinal products ... See more keywords
Managing access to advanced therapy medicinal products: Challenges for NHS Wales
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14286
Abstract: Advanced Therapy Medicinal Products (ATMPs), which include gene, somatic cell therapies and tissue‐engineered medicines, have the potential to transform current care pathways by offering durable and potentially curative outcomes. However, they are exceptionally expensive, with… read more here.
Keywords: therapy medicinal; access advanced; medicinal products; advanced therapy ... See more keywords